Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

Talya Greene; Sharif El-Leithy; Jo Billings; Idit Albert; Jennifer Birch; Mari Campbell; Kim Ehntholt; Lorna Fortune; Nicola Gilbert; Nick Grey; Laurinne Hana; Helen Kennerley; Deborah Lee; Sarah Lunn; Dominic Murphy; Mary Robertson; Dorothy Wade; Chris R. Brewin; Michael A.P. Bloomfield

doi:10.1080/20008198.2021.1959707

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

Talya Greene, Sharif El-Leithy, Jo Billings, Idit Albert, Jennifer Birch, Mari Campbell, Kim Ehntholt, Lorna Fortune, Nicola Gilbert, Nick Grey, Laurinne Hana, Helen Kennerley, Deborah Lee, Sarah Lunn, Dominic Murphy, Mary Robertson, Dorothy Wade, Chris R. Brewin, Michael A.P. Bloomfield

Department of Community Mental Health

Research output: Contribution to journal › Letter › peer-review

Abstract

Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

Original language	English
Article number	1959707
Journal	European Journal of Psychotraumatology
Volume	13
Issue number	1
DOIs	https://doi.org/10.1080/20008198.2021.1959707
State	Published - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Keywords

PTSD assessment
Psychological trauma
critical care
intensive care
long COVID
mental health screening
COVID-19/epidemiology
Mass Screening
Pandemics
Humans
Survivors/psychology
Stress Disorders, Post-Traumatic/diagnosis

ASJC Scopus subject areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/20008198.2021.1959707

Cite this

Greene, T., El-Leithy, S., Billings, J., Albert, I., Birch, J., Campbell, M., Ehntholt, K., Fortune, L., Gilbert, N., Grey, N., Hana, L., Kennerley, H., Lee, D., Lunn, S., Murphy, D., Robertson, M., Wade, D., Brewin, C. R., & Bloomfield, M. A. P. (2022). Anticipating PTSD in severe COVID survivors: the case for screen-and-treat. European Journal of Psychotraumatology, 13(1), [1959707]. https://doi.org/10.1080/20008198.2021.1959707

@article{1dad7151794b407ba8080fe646104fd5,

title = "Anticipating PTSD in severe COVID survivors: the case for screen-and-treat",

abstract = "Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.",

keywords = "PTSD assessment, Psychological trauma, critical care, intensive care, long COVID, mental health screening, COVID-19/epidemiology, Mass Screening, Pandemics, Humans, Survivors/psychology, Stress Disorders, Post-Traumatic/diagnosis",

author = "Talya Greene and Sharif El-Leithy and Jo Billings and Idit Albert and Jennifer Birch and Mari Campbell and Kim Ehntholt and Lorna Fortune and Nicola Gilbert and Nick Grey and Laurinne Hana and Helen Kennerley and Deborah Lee and Sarah Lunn and Dominic Murphy and Mary Robertson and Dorothy Wade and Brewin, {Chris R.} and Bloomfield, {Michael A.P.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2022",

doi = "10.1080/20008198.2021.1959707",

language = "English",

volume = "13",

journal = "European Journal of Psychotraumatology",

issn = "2000-8198",

publisher = "Co-Action Publishing",

number = "1",

}

Greene, T, El-Leithy, S, Billings, J, Albert, I, Birch, J, Campbell, M, Ehntholt, K, Fortune, L, Gilbert, N, Grey, N, Hana, L, Kennerley, H, Lee, D, Lunn, S, Murphy, D, Robertson, M, Wade, D, Brewin, CR & Bloomfield, MAP 2022, 'Anticipating PTSD in severe COVID survivors: the case for screen-and-treat', European Journal of Psychotraumatology, vol. 13, no. 1, 1959707. https://doi.org/10.1080/20008198.2021.1959707

TY - JOUR

T1 - Anticipating PTSD in severe COVID survivors

T2 - the case for screen-and-treat

AU - Greene, Talya

AU - El-Leithy, Sharif

AU - Billings, Jo

AU - Albert, Idit

AU - Birch, Jennifer

AU - Campbell, Mari

AU - Ehntholt, Kim

AU - Fortune, Lorna

AU - Gilbert, Nicola

AU - Grey, Nick

AU - Hana, Laurinne

AU - Kennerley, Helen

AU - Lee, Deborah

AU - Lunn, Sarah

AU - Murphy, Dominic

AU - Robertson, Mary

AU - Wade, Dorothy

AU - Brewin, Chris R.

AU - Bloomfield, Michael A.P.

PY - 2022

Y1 - 2022

N2 - Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

AB - Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

KW - PTSD assessment

KW - Psychological trauma

KW - critical care

KW - intensive care

KW - long COVID

KW - mental health screening

KW - COVID-19/epidemiology

KW - Mass Screening

KW - Pandemics

KW - Humans

KW - Survivors/psychology

KW - Stress Disorders, Post-Traumatic/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85123725184&partnerID=8YFLogxK

U2 - 10.1080/20008198.2021.1959707

DO - 10.1080/20008198.2021.1959707

M3 - Letter

C2 - 35096282

AN - SCOPUS:85123725184

SN - 2000-8198

VL - 13

JO - European Journal of Psychotraumatology

JF - European Journal of Psychotraumatology

IS - 1

M1 - 1959707

ER -

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this